P863 KEYNOTE-022 Parts 4 and 5: Pembrolizumab Plus Trametinib for Patients with Solid Tumors or BRAF Wild-Type Melanoma
Poster presentations(2020)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined